Showing results (101-110 of 140) with videos related to
Sort By:
Pageof 14
International Journal of Cancer|February 22, 2005
Response of malignant B lymphocytes to ionizing radiation: gene expression and genotypeHeidi Lyng, Kirsti S Landsverk, Elin Kristiansen, et al.The Journal of Biological Chemistry|December 23, 1994
1,25-dihydroxyvitamin D3 alters the effect of cAMP in thyroid cells by increasing the regulatory subunit type II beta of the cAMP-dependent protein kinaseJ P Berg, A H Ree, J A Sandvik, et al.BMC Plant Biology|July 11, 2015
Towards a comprehensive phylogeny of the large temperate genus Pedicularis (Orobanchaceae), with an emphasis on species from the Himalaya-Hengduan MountainsWen-Bin Yu, Min-Lu Liu, Hong Wang, et al.European Journal of Gynaecological Oncology|October 31, 2007
Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formationT Paulsen, A H Ree, J Kaern, et al.Science (New York, N.Y.)|May 6, 1988
The nature of the interior of uranus based on studies of planetary ices at high dynamic pressureW J Nellis, D C Hamilton, N C Holmes, et al.Acta Oncologica (Stockholm, Sweden)|October 19, 2025
Low b-values in apparent diffusion coefficient calculations overestimate diffusion in rectal cancerJohanna A Hundvin, Marius Bornstein, Anne Negård, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2020
177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin LymphomaMarion M Malenge, Sebastian Patzke, Anne H Ree, et al.Endocrinology|August 1, 1994
1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alphaJ P Berg, J A Sandvik, A H Ree, et al.Urology|December 26, 2007
Sacral neuromodulation: cost considerations and clinical benefitsSherif R Aboseif, Dennis H Kim, Jocelyn M Rieder, et al.Plos One|September 12, 2013
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanomaAndliena Tahiri, Kathrine Røe, Anne H Ree, et al.Pageof 14